| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,859 |
5,262 |
$312K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,949 |
2,729 |
$224K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
671 |
670 |
$46K |
| 99215 |
Prolong outpt/office vis |
144 |
141 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
462 |
454 |
$12K |
| 87428 |
|
129 |
128 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
531 |
503 |
$2K |
| 99443 |
|
15 |
15 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
14 |
14 |
$1K |
| 99050 |
|
147 |
144 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16 |
16 |
$654.36 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
54 |
54 |
$629.33 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17 |
16 |
$504.63 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
37 |
36 |
$482.59 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14 |
14 |
$306.47 |
| 81003 |
|
128 |
124 |
$202.42 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
13 |
$159.14 |
| 92567 |
|
15 |
14 |
$138.79 |
| 90688 |
|
13 |
13 |
$104.36 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$86.80 |